Remove 2011 Remove Patients Remove Pharma Remove Prescription
article thumbnail

Thursday pharma headlines

World of DTC Marketing

regulators knew about reports of suicidal behavior in men taking the anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label. prescriptions of finasteride, as the drug is known, for hair loss increased to over 2.4 Annual U.S. COVID Dashboards.

Pharma 180
article thumbnail

Voice is Becoming the Loudest Tool in the Exam Room

PM360

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. While this sort of innovation might not be a surprise in the automotive category, its breadth of functional benefits for patients and healthcare providers (HCPs) might be.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. Currently, an estimated 37.3 of the U.S.

Retail 52
article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. And he’s also a Pharma Marketing Network Editorial Advisory Board member. At the moment, it started off with, you know, five 8 10 million in 2011. Do you think that that’s happening within pharma now? I’ll be your host today.

Pharma 52
article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. And he’s also a Pharma Marketing Network Editorial Advisory Board member. At the moment, it started off with, you know, five 8 10 million in 2011. Do you think that that’s happening within pharma now? I’ll be your host today.

Pharma 40
article thumbnail

Everything You Need to Know About Market Access in China

PM360

Additionally, it will delve into the current trends and challenges that pharma companies need to consider when devising successful market access strategies for this unique market. Medicines that are not listed in either Category 1 or 2, such as over the counter (OTC) and other prescription therapies (pembrolizumab, CAR-T therapy, etc.),

Marketing 105